Growth of the vascular tree

Paediatric Respiratory Reviews

Volumn 1, Issue 4, 2000, Pages 321-328

  Hislop, A A ^a   Pierce, C M ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Development; Endothelin; Endothelium; Nitric oxide; Pulmonary circulation; Pulmonary hypertension

Indexed keywords

ADAPTATION; CONFERENCE PAPER; HUMAN; LUNG; NEWBORN; PATHOPHYSIOLOGY; PERSISTENT FETUS CIRCULATION; PHYSIOLOGY; PRENATAL DEVELOPMENT; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; HUMANS; INFANT, NEWBORN; LUNG; PERSISTENT FETAL CIRCULATION SYNDROME;

EID: 10644260558     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2000.0071     Document Type: Article

References (17)

1. Hislop AA, Reid LM. Formation of the pulmonary vasculature. In: Hodson WA (ed). Development of the Lung Monograph. New York: Marcel Dekker, 1977: 37-86.
2. Hall SM, Hislop AA, Pierce C, Haworth SG. Prenatal origins of human intrapulmonary arteries: formation and maturation. Am J Respir Cell Mol Biol 2000; 23: 194-203.
3. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA (ed). Lung Growth and Development. New York: Marcel Dekker, 1997: 1-35.
4. Haworth SG. Pulmonary hypertension in childhood. Eur Respir J 1993; 6: 1037-1043.
5. Morrell NW, Weiser MCM, Stenmark KR. Development of the Pulmonary Vasculature. In: Gaultier C, Bourbon JR, Post M. (eds). Lung Development. Oxford: Oxford University Press, 1999: 152-195.
6. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell 1996; 87: 1153-1155.
7. Dukarm RC, Steinhorn RH, Morin III FC. The normal pulmonary vascular transition at birth. Clin Perinatal 1996; 23: 711-726.
8. Abman S, Kinsella JP, MercierJ-C. Nitric oxide and endothelin in the developing pulmonary circulation: physiologic and clinical implications. In: Gaultier C, Bourbon JR, Post M (eds). Lung Development. Oxford: Oxford University Press, 1999: 196-220.
9. Haworth SG. The pathophysiology of persistent pulmonary hypertension of the newborn. Semin Neonatal 1997; 2: 13-23.
10. Hislop AA, Springall DR, Buttery LDK, Pollock JS, Haworth SG. Abundance of endothelial nitric oxide synthase in newborn intrapulmonary arteries. Arch Dis Child 1995; 12: F17-F21.
11. MacAllister RJ, Fickling SA, Whitley GStJ, Vallance P. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 1994; 112: 43-48.
12. Pagan KA, Fouty BW, Tyler RC, Morris Jr KG, Hepler LKSK, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, Rodman DM. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresonsive to mild hypoxia. J Clin Invest 1999; 103: 291-299.
13. Noguchi Y, Hislop AA, Haworth SG. Influence of hypoxia on endothelin-I binding sites in neonatal porcine pulmonary vasculature. AmJ Physiol 1997; 272: H669-H678.
14. Shehata SMK, Tibboel D, Sharma HS, Mooi WJ. Impaired structural remodelling of pulmonary arteries n newborns with congenital diaphragmatic hernia: a histological study of 29 cases. J Pathol 1999; 189: 112-118.
15. Nichols WC, Koller DL, Slovis B, Foroud T, Terry VH, Arnold ND, Siemieniak DR, Wheeler L, Phillips JAI, Newman JH, Conneally PM, Ginsburg D, Lloyd JE. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997; 15: 277-280.
16. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson JJ. (eds). Chronic lung disease in early infancy. New York: Marcel Dekker, 2000: 85-124.
17. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. New England J Med 2000; 342: 469-474.